PSA Test Often Occurs Without Discussion of Benefits, Harms

This article originally appeared here.
Share this content:
PSA Test Often Occurs Without Discussion of Benefits, Harms
PSA Test Often Occurs Without Discussion of Benefits, Harms

WEDNESDAY, April 12, 2017 (HealthDay News) -- Fewer than one in three men screened with the prostate-specific antigen (PSA) test for prostate cancer talked about the risks and benefits of the test with their doctor, according to a study published online recently in Urology.

Before the 2012 U.S. Preventive Services Task Force (USPSTF) recommendation was made, a survey conducted that same year found that only 30.1 percent of patients had discussed both the risks and benefits of PSA testing with their doctor. Slightly more -- 30.5 percent -- said they had no discussion about these issues, 38.5 percent only talked about the advantages of PSA testing, and 0.8 percent discussed only the disadvantages.

Two years later, a survey of 111,241 men found little change --- only 29.5 percent reported discussing both the pros and cons of PSA testing. Another 33.9 percent had no discussion at all about risks or benefits, and 35.7 percent of men talked with their doctors only about the benefits of screening. In 2012, 63.0 percent of men underwent PSA tests. In 2014, that number decreased slightly, to 62.4 percent, the researchers found. Men who were more likely to undergo testing without being aware of all the risks and benefits involved had low incomes, lacked a high school diploma, were uninsured, or were Hispanic.

"We believe our findings may be indicative of a shift in practice patterns away from detailed prescreening discussions among health care providers who have implemented the 2012 (USPSTF) recommendation into their caregiving," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

ACG: Diphenhydramine Ups Sedation in Chronic Opioid Users

ACG: Diphenhydramine Ups Sedation in Chronic Opioid Users

Improvement in sedation scores for patients using chronic opioids scheduled to undergo colonoscopy

Online Ratings Not Aligned With Objective Quality Measures

Online Ratings Not Aligned With Objective Quality Measures

In addition, consumer ratings are consistent across platforms for specialist physicians

Most Female Physicians Have Faced Sexist Patient Comments

Most Female Physicians Have Faced Sexist Patient Comments

Sexual harassment by patients can negatively affect physician-patient relationship, quality of care

is free, fast, and customized just for you!

Already a member?

Sign In Now »